- Home
- AMPH vs NVGS Comparison
AMPH vs NVGS Comparison
Compare AMPH & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPH
- NVGS
- Stock Information
- Founded
- AMPH 1996
- NVGS 1997
- Country
- AMPH United States
- NVGS United Kingdom
- Employees
- AMPH N/A
- NVGS N/A
- Industry
- AMPH Biotechnology: Pharmaceutical Preparations
- NVGS Marine Transportation
- Sector
- AMPH Health Care
- NVGS Consumer Discretionary
- Exchange
- AMPH Nasdaq
- NVGS Nasdaq
- Market Cap
- AMPH 1.1B
- NVGS 994.3M
- IPO Year
- AMPH 2014
- NVGS N/A
- Fundamental
- Price
- AMPH $21.67
- NVGS $16.42
- Analyst Decision
- AMPH Hold
- NVGS Strong Buy
- Analyst Count
- AMPH 5
- NVGS 3
- Target Price
- AMPH $38.00
- NVGS $22.00
- AVG Volume (30 Days)
- AMPH 462.5K
- NVGS 517.6K
- Earning Date
- AMPH 08-07-2025
- NVGS 08-13-2025
- Dividend Yield
- AMPH N/A
- NVGS 1.21%
- EPS Growth
- AMPH N/A
- NVGS 9.28
- EPS
- AMPH 2.77
- NVGS 1.27
- Revenue
- AMPH $730,659,000.00
- NVGS $583,931,000.00
- Revenue This Year
- AMPH $0.92
- NVGS $3.45
- Revenue Next Year
- AMPH $5.55
- NVGS N/A
- P/E Ratio
- AMPH $7.84
- NVGS $12.79
- Revenue Growth
- AMPH 8.05
- NVGS 6.38
- 52 Week Low
- AMPH $20.43
- NVGS $10.55
- 52 Week High
- AMPH $53.96
- NVGS $17.53
- Technical
- Relative Strength Index (RSI)
- AMPH 41.15
- NVGS 65.96
- Support Level
- AMPH $20.43
- NVGS $15.97
- Resistance Level
- AMPH $22.90
- NVGS $16.72
- Average True Range (ATR)
- AMPH 0.73
- NVGS 0.36
- MACD
- AMPH 0.15
- NVGS 0.04
- Stochastic Oscillator
- AMPH 50.20
- NVGS 83.24
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.